Five Biotech Stocks With Big Potential And Billionaire Believers – Forbes
|
Five Biotech Stocks With Big Potential And Billionaire Believers
Forbes Last week the biotech stock Idenix Pharmaceuticals was acquired by Merck for a 229% premium. Billionaire and top hedge fund manager Seth Klarman, of the Baupost Group, made over billion on his investment in Idenix, in one day. Klarman owned … 3 Biotech Stocks Backed By Big Money |
